UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3078-3081

1998

Volltextzugriff (PDF)

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1728-1733

2001

Volltextzugriff (PDF)

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes

Cancer research (Chicago, Ill.), 1992-08, Vol.52 (16), p.4379-4384

1992

Volltextzugriff (PDF)

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer

Seminars in oncology, 1997-08, Vol.24 (4 Suppl 12), p.S12

1997

Volltextzugriff (PDF)

Triple-negative breast cancer in Hong Kong Chinese patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e22127-e22127

2009

Volltextzugriff (PDF)

Chemoradiotherapy for poor-risk stage III non-small cell lung cancer

Seminars in oncology, 1997-08, Vol.24 (4 Suppl 12), p.S12

1997

Volltextzugriff (PDF)

Randomized trial of concurrent versus sequential docetaxel (Doc) plus bortezomib (PS-341) in platinum pretreated non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7533-7533

2010

Volltextzugriff (PDF)

Long-term survival with gefitinib (ZD 1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) study S0126

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8047-8047

2008

Volltextzugriff (PDF)

Irinotecan and carboplatin for treatment of brain metastases from small-cell lung cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19032-19032

2008

Volltextzugriff (PDF)

KT3.2 and KT3.3, Two Novel Human Two-Pore K+ Channels Closely Related to TASK-1

Journal of neurophysiology, 2001-07, Vol.86 (1), p.130-142

2001

Volltextzugriff (PDF)

Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3552-3552

2009

Volltextzugriff (PDF)

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel

Cancer, 2001-07, Vol.92 (1), p.146-152

2001

Volltextzugriff (PDF)

Intermittent erlotinib (ERL) in combination with pemetrexed (PEM): Phase I schedules designed to achieve pharmacodynamic separation

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8032-8032

2008

Volltextzugriff (PDF)

Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19009-19009

2008

Volltextzugriff (PDF)

Rash severity and dose in phase I dose escalation cetuximab (C225) trial

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14573-14573

2008

Volltextzugriff (PDF)

Resection of multifocal non–small cell lung cancer when the bronchioloalveolar subtype is involved

Journal of thoracic and cardiovascular surgery, 2003-11, Vol.126 (5), p.1597-1601

2003

Volltextzugriff (PDF)

Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer

American journal of otolaryngology, 2013-11, Vol.34 (6), p.631-635

2013

Volltextzugriff (PDF)

Responsiveness of the Michigan Hand Outcomes Questionnaire and Physical Measurements in Outcome Studies of Distal Radius Fracture Treatment

The Journal of hand surgery (American ed.), 2007, Vol.32 (1), p.84-90

2007

Volltextzugriff (PDF)

Intermittent erlotinib in combination with docetaxel (DOC): Phase I schedules designed to achieve pharmacodynamic separation

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7038-7038

2005

Volltextzugriff (PDF)

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7056-7056

2004

Volltextzugriff (PDF)

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7056-7056

2004

Volltextzugriff (PDF)

Typologie des systèmes d'élevage de l'agriculture familiale amazonienne: le cas du municipe d'Uruará, Brésil

Revue d'élevage et de médecine vétérinaire des pays tropicaux, 2001-03, Vol.54 (3-4), p.239-246

2001

Volltextzugriff (PDF)

The proteasome inhibitor, bortezomib, in combination with gemcitabine (Gem) and carboplatin (Carbo) in advanced non-small cell lung cancer (NSCLC): Final results of a phase I California Cancer Consortium study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7106-7106

2004

Volltextzugriff (PDF)

The proteasome inhibitor, bortezomib, in combination with gemcitabine (Gem) and carboplatin (Carbo) in advanced non-small cell lung cancer (NSCLC): Final results of a phase I California Cancer Consortium study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7106-7106

2004

Volltextzugriff (PDF)

Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7014-7014

2004

Volltextzugriff (PDF)

1 – 25 von 838

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(787)
Mit Volltextzugriff
(661)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer

Triple-negative breast cancer in Hong Kong Chinese patients

Chemoradiotherapy for poor-risk stage III non-small cell lung cancer

Randomized trial of concurrent versus sequential docetaxel (Doc) plus bortezomib (PS-341) in platinum pretreated non-small cell lung cancer (NSCLC)

Long-term survival with gefitinib (ZD 1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) study S0126

Irinotecan and carboplatin for treatment of brain metastases from small-cell lung cancer

KT3.2 and KT3.3, Two Novel Human Two-Pore K+ Channels Closely Related to TASK-1

Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel

Intermittent erlotinib (ERL) in combination with pemetrexed (PEM): Phase I schedules designed to achieve pharmacodynamic separation

Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival

Rash severity and dose in phase I dose escalation cetuximab (C225) trial

Resection of multifocal non–small cell lung cancer when the bronchioloalveolar subtype is involved

Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer

Responsiveness of the Michigan Hand Outcomes Questionnaire and Physical Measurements in Outcome Studies of Distal Radius Fracture Treatment

Intermittent erlotinib in combination with docetaxel (DOC): Phase I schedules designed to achieve pharmacodynamic separation

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Typologie des systèmes d'élevage de l'agriculture familiale amazonienne: le cas du municipe d'Uruará, Brésil

The proteasome inhibitor, bortezomib, in combination with gemcitabine (Gem) and carboplatin (Carbo) in advanced non-small cell lung cancer (NSCLC): Final results of a phase I California Cancer Consortium study

The proteasome inhibitor, bortezomib, in combination with gemcitabine (Gem) and carboplatin (Carbo) in advanced non-small cell lung cancer (NSCLC): Final results of a phase I California Cancer Consortium study

Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126

Aktive Filter

Suchergebnisse filtern